Aboiants R K, Istranov L P, Shekhter A B, Rudenko T G, Istranova E V, Antipas D B, Kurdiumov S G
Stomatologiia (Mosk). 1996;75(5):23-5.
Hapcol, a new osteoplastic material, representing a biological composition on the basis of a natural biopolymer collagen with biologically compatible osteotropic mineral hydroxyapatite has been developed and allowed for clinical use. It is intended for use in dentistry in surgical treatment of periodontal diseases, deformations of the abutment tissues of the face, filling of bone defects after cystectomy, surgery for bone plasty, etc. Hapcol is characterized by antiinflammatory action, stimulates repair osteogenesis and collagenogenesis. Joint stock company Polistom starts commercial manufacture of the new material.
哈普科尔（Hapcol）是一种新型骨塑性材料，它是一种基于天然生物聚合物胶原蛋白与生物相容性促骨矿物质羟基磷灰石的生物组合物，现已研发成功并获准临床使用。它适用于牙科领域，用于牙周疾病的外科治疗、面部基牙组织畸形矫正、囊肿切除术后骨缺损填充、骨成形手术等。哈普科尔具有抗炎作用，能刺激修复性骨生成和胶原生成。波利斯托姆股份公司开始对这种新材料进行商业化生产。
